Evidence map›Paper›PMID 17369310›Full record

ArticleRNA (New York, N.Y.)2007

Editing modifies the GABA(A) receptor subunit alpha3.

Johan Ohlson, Jakob Skou Pedersen, David Haussler, Marie Ohman

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed.

  1. RNA splicing in health and disease.Molecular biomedicine · 2026
    Review
  2. Two codes of RNA editing by deamination in human diseases.Experimental & molecular medicine · 2026
    Review
  3. Evolution of Engineered ADAR-Based RNA Editing Systems.International journal of molecular sciences · 2026
    Review
  4. De novo rates of aProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. The role of RNA editing enzyme ADAR1 in human disease.Wiley interdisciplinary reviews. RNA · 2022
    Review
  16. Review
  17. Article
  18. GABAIUPHAR/BPS guide to pharmacology CITE · 2021
    Article
  19. Review
  20. Review

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Johan OhlsonDepartment of Molecular Biology and Functional Genomics, Stockholm University, SE-106 91 Stockholm, Sweden.
Jakob Skou Pedersen
David Haussler
Marie Ohman

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenosine to inosine (A-to-I) pre-mRNA editing by the ADAR enzyme family has the potential to increase the variety of the proteome. This editing by adenosine deamination is essential in mammals for a functional brain. To detect novel substrates for A-to-I editing we have used an experimental method to find selectively edited sites and combined it with bioinformatic techniques that find stem-loop structures suitable for editing. We present here the first verified editing candidate detected by this screening procedure. We show that Gabra-3, which codes for the alpha3 subunit of the GABA(A) receptor, is a substrate for editing by both ADAR1 and ADAR2. Editing of the Gabra-3 mRNA recodes an isoleucine to a methionine. The extent of editing is low at birth but increases with age, reaching close to 100% in the adult brain. We therefore propose that editing of the Gabra-3 mRNA is important for normal brain development.

Indexed as

Adenosine DeaminaseAnimalsAnimals, NewbornBrainCells, CulturedGene Expression Regulation, DevelopmentalHumansIsoleucineMethionineMiceMice, Inbred StrainsMice, Mutant StrainsReceptors, GABA-ARNA-Binding ProteinsRNA EditingADARB1 protein, humanAdenosine DeaminaseGABRA3 protein, humanGabra3 protein, mouseIsoleucineMethionineReceptors, GABA-ARNA-Binding Proteins

Identifiers

PMID17369310
PMCPMC1852825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.